Entero Healthcare Solutions Limited (NSE:ENTERO)
India
· Delayed Price · Currency is INR 1,174.00
-36.80 (-3.04%)
Mar 13, 2025, 3:30 PM IST
NSE:ENTERO Revenue
Entero Healthcare Solutions had revenue of 13.59B INR in the quarter ending December 31, 2024, with 36.91% growth. This brings the company's revenue in the last twelve months to 47.91B, up 26.90% year-over-year. In the fiscal year ending March 31, 2024, Entero Healthcare Solutions had annual revenue of 39.22B with 18.85% growth.
Revenue (ttm)
47.91B
Revenue Growth
+26.90%
P/S Ratio
1.04
Revenue / Employee
14.79M
Employees
3,240
Market Cap
51.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 39.22B | 6.22B | 18.85% |
| Mar 31, 2023 | 33.00B | 7.78B | 30.85% |
| Mar 31, 2022 | 25.22B | 7.49B | 42.24% |
| Mar 31, 2021 | 17.73B | 4.23B | 31.38% |
| Mar 31, 2020 | 13.50B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Zydus Lifesciences | 222.47B |
| Apollo Hospitals Enterprise | 211.46B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |